Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Dec;63(12):1581–1586. doi: 10.1136/ard.2003.012294

HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis

J Morel 1, F Roch-Bras 1, N Molinari 1, J Sany 1, J Eliaou 1, B Combe 1
PMCID: PMC1754841  PMID: 15547082

Abstract

Objective: To evaluate HLA-DM alleles as markers for disease severity in rheumatoid arthritis (RA).

Methods: Two distinct cohorts of patients with RA were oligotyped for HLA-DB1 and HLA-DM genes using PCR amplified genomic DNA with sequence specific oligonucleotide probes. Cohort 1 comprised 199 unselected patients with RA (mean (SD) age 45.5 (13.5) years; disease duration 11.9(8.8) years), whose disease severity was assessed using Larsen score on hand and foot radiographs. Cohort 2 comprised 95 patients with severe RA and 70 patients with benign RA according to the Larsen method.

Results: In cohort 1, after stratification according to DRB1 genotypes, patients positive for HLA-DMA*0103 and negative for HLA-DRB1*04 tended to have greater articular damage on hands and wrists (p = 0.07 by Mann-Whitney U test) and reached statistical significance for the Larsen score per year (p = 0.05). This association between HLA-DMA*0103 and articular damage was especially observed in patients with HLA-DRB1*01. Similarly, HLA-DMB*0104 positive patients had higher Larsen score on hands and wrists (p = 0.02). This association was even stronger in DRB1*04 positive patients (p = 0.005). In cohort 2, HLA-DMA*0103 was associated with severe RA in patients negative for HLA-DRB1*04 (OD = 5.4; p = 0.014). HLA-DMB*0104 allele frequency tended to be higher in patients with severe RA but without reaching significance.

Conclusion: This is the first study evaluating the role of HLA-DM genes in the severity of RA. Our results suggest that HLA-DMA*0103 and HLA-DMB*0104 alleles may represent new genetic markers of RA severity. The HLA-DMA*0103 allele tends to be associated with patients with RA negative for DRB1*04 and could predict a more severe form of disease especially in HLA-DRB1*01 positive patients. The HLA-DMB*0104 allele could have an additive effect in HLA-DRB1*04 patients. Combined determination of HLA-DM and HLA-DRB1 alleles could facilitate identification of patients likely to have a poor disease course.

Full Text

The Full Text of this article is available as a PDF (79.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón G. S. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 1995 Aug;21(3):589–604. [PubMed] [Google Scholar]
  2. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Bontrop R. E., Charron D., Dupont B., Erlich H. A., Fauchet R., Mach B. Nomenclature for factors of the HLA System, 1996. Hum Immunol. 1997 Mar;53(1):98–128. doi: 10.1016/S0198-8859(97)00031-1. [DOI] [PubMed] [Google Scholar]
  3. Combe B., Eliaou J. F., Daurès J. P., Meyer O., Clot J., Sany J. Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol. 1995 Jun;34(6):529–534. doi: 10.1093/rheumatology/34.6.529. [DOI] [PubMed] [Google Scholar]
  4. Cucchi-Mouillot P., Lai S., Carcassi C., Sorba P., Stuart-Simoni M., Amoros J. P., Genetet B., Haras D., Contu L. Implication of HLA-DMA alleles in corsican IDDM. Dis Markers. 1998 Nov;14(3):135–141. doi: 10.1155/1998/705857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Emery P., Salmon M., Bradley H., Wordsworth P., Tunn E., Bacon P. A., Waring R. Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ. 1992 Dec 5;305(6866):1387–1389. doi: 10.1136/bmj.305.6866.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kropshofer H., Hämmerling G. J., Vogt A. B. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today. 1997 Feb;18(2):77–82. doi: 10.1016/s0167-5699(97)01006-2. [DOI] [PubMed] [Google Scholar]
  7. Masi A. T. Articular patterns in the early course of rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):16–26. doi: 10.1016/0002-9343(83)90471-0. [DOI] [PubMed] [Google Scholar]
  8. Mason J. H., Anderson J. J., Meenan R. F. A model of health status for rheumatoid arthritis. A factor analysis of the Arthritis Impact Measurement Scales. Arthritis Rheum. 1988 Jun;31(6):714–720. doi: 10.1002/art.1780310603. [DOI] [PubMed] [Google Scholar]
  9. McTernan C. L., Mijovic C. H., Cockram C. S., Barnett A. H. The nucleotide sequence of a new DMB allele, DMB*0106. Tissue Antigens. 2000 May;55(5):470–472. doi: 10.1034/j.1399-0039.2000.550514.x. [DOI] [PubMed] [Google Scholar]
  10. Meenan R. F., Mason J. H., Anderson J. J., Guccione A. A., Kazis L. E. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992 Jan;35(1):1–10. doi: 10.1002/art.1780350102. [DOI] [PubMed] [Google Scholar]
  11. Meyer O., Labarre C., Dougados M., Goupille Ph, Cantagrel A., Dubois A., Nicaise-Roland P., Sibilia J., Combe B. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis. 2003 Feb;62(2):120–126. doi: 10.1136/ard.62.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moxley G., Han J. HLA DMA and DMB show no association with rheumatoid arthritis in US Caucasians. Eur J Immunogenet. 2001 Oct;28(5):539–543. doi: 10.1046/j.1365-2370.2001.00258.x. [DOI] [PubMed] [Google Scholar]
  13. Nepom G. T., Byers P., Seyfried C., Healey L. A., Wilske K. R., Stage D., Nepom B. S. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum. 1989 Jan;32(1):15–21. doi: 10.1002/anr.1780320104. [DOI] [PubMed] [Google Scholar]
  14. Pathak S. S., Lich J. D., Blum J. S. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM. J Immunol. 2001 Jul 15;167(2):632–635. doi: 10.4049/jimmunol.167.2.632. [DOI] [PubMed] [Google Scholar]
  15. Perdriger A., Guggenbuhl P., Chalès G., Yaouanq J., Quelvennec E., Bonnard M. N., Pawlotsky Y., Semana G. Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis. Rheumatology (Oxford) 1999 May;38(5):448–452. doi: 10.1093/rheumatology/38.5.448. [DOI] [PubMed] [Google Scholar]
  16. Pinet V., Combe B., Avinens O., Caillat-Zucman S., Sany J., Clot J., Eliaou J. F. Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum. 1997 May;40(5):854–858. doi: 10.1002/art.1780400512. [DOI] [PubMed] [Google Scholar]
  17. Reviron D., Tezenas du Montcel S., Foutrier C., Guis S., Benazet J. F., Auquier P., Busson M., Roux H., Mercier P., Roudier J. HLA DRB1, DMA, and DMB gene polymorphisms in rheumatoid arthritis. Hum Immunol. 1999 Mar;60(3):245–249. doi: 10.1016/s0198-8859(98)00116-5. [DOI] [PubMed] [Google Scholar]
  18. Singal D. P., Ye M. HLA-DM polymorphisms in patients with rheumatoid arthritis. J Rheumatol. 1998 Jul;25(7):1295–1298. [PubMed] [Google Scholar]
  19. Spies T., Sorrentino R., Boss J. M., Okada K., Strominger J. L. Structural organization of the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5165–5169. doi: 10.1073/pnas.82.15.5165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Symmons D. P., Barrett E. M., Bankhead C. R., Scott D. G., Silman A. J. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994 Aug;33(8):735–739. doi: 10.1093/rheumatology/33.8.735. [DOI] [PubMed] [Google Scholar]
  21. Takeuchi F., Nabeta H., Kuwata S., Tanimoto K., Ito K. Association of DMA and DMB with RA in Japanese. Clin Exp Rheumatol. 1997 Mar-Apr;15(2):189–192. [PubMed] [Google Scholar]
  22. Toussirot E., Sauvageot C., Chabod J., Ferrand C., Tiberghien P., Wendling D. The association of HLA-DM genes with rheumatoid arthritis in Eastern France. Hum Immunol. 2000 Mar;61(3):303–308. doi: 10.1016/s0198-8859(99)00126-3. [DOI] [PubMed] [Google Scholar]
  23. Wagner U., Kaltenhäuser S., Sauer H., Arnold S., Seidel W., Häntzschel H., Kalden J. R., Wassmuth R. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum. 1997 Feb;40(2):341–351. doi: 10.1002/art.1780400219. [DOI] [PubMed] [Google Scholar]
  24. Weyand C. M., McCarthy T. G., Goronzy J. J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995 May;95(5):2120–2126. doi: 10.1172/JCI117900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Weyand C. M., Xie C., Goronzy J. J. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest. 1992 Jun;89(6):2033–2039. doi: 10.1172/JCI115814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yen J. H., Chen C. J., Tsai W. C., Tsai J. J., Chang J. G., Liu H. W. HLA-DMA and DMB genotyping in patients with rheumatoid arthritis. J Rheumatol. 1997 Mar;24(3):442–444. [PubMed] [Google Scholar]
  27. van der Heijde D. M., van Riel P. L., Nuver-Zwart I. H., Gribnau F. W., vad de Putte L. B. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989 May 13;1(8646):1036–1038. doi: 10.1016/s0140-6736(89)92442-2. [DOI] [PubMed] [Google Scholar]
  28. van der Heijde D. M., van Riel P. L., van Leeuwen M. A., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol. 1992 Aug;31(8):519–525. doi: 10.1093/rheumatology/31.8.519. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES